Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro

Cancer Research

Volumn 57, Issue 1, 1997, Pages 141-146

  Okamoto, Masato ^a   Lee, Chung ^a   Oyasu, Ryoichi ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; RECOMBINANT INTERLEUKIN 6;

ARTICLE; AUTOCRINE EFFECT; CARCINOMA CELL; CELL GROWTH; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; STROMA CELL;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, CD; CELL DIVISION; CULTURE MEDIA, CONDITIONED; CYTOKINE RECEPTOR GP130; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0031014669     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kishimoto, T. The biology of interleukin-6. Blood, 74: 1-10, 1989.
2. Le, J., and Vilcek, J. Interleukin-6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab. Invest., 61: 588-602, 1989.
3. Eustace, D., Han, X., Gooding, R., Rowbottom, A., Riches, P., and Heyderman, E. Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Gynecol. Oncol., 50: 15-19, 1993.
4. Miki, S., Iwano, M., Miki, Y., Yamamoto, M., Tang, B., Yokokawa, K., Sonoda, T., Hirano, T., and Kishimoto, T. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett., 250: 607-610, 1989.
5. Lahm, H., Petral-Malec, D., Yilmaz-Ceyhan, A., Fischer, J. R., Lorenzoni, M., Givel, J. C., and Odartchenko, N. Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor β1. Eur. J. Cancer, 28A: 1894-1899, 1992.
6. Chen, L., Mory, Y., Zilberstein A., and Revel M. Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-β2. Proc. Natl. Acad. Sci. USA, 85: 8037-8041, 1988.
7. Tam I., Cardinale, I., Krueger, J., Murphy, J. S., May, L. T., and Sehgal, P. B. Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J. Exp. Med., 170: 1649-1669, 1989.
8. Tabibzadeh, S. S., Poubouridis, D., May, L. T., and Sehgal, P. B. Interleukin-6 immunoreactivity in human tumors. Am. J. Pathol., 135: 427-433, 1989.
9. Takenawa, J., Kaneko, Y., Fukumoto, M., Fukatsu, A., Hirano, T., Fukuyama, H., Nakayama, H., Fujita, J., and Yoshida, O. Enhanced expression of interleukin-6 in primary human renal carcinomas. J. Natl. Cancer Inst., 83: 1668-1672, 1991.
10. Yamamoto, M., Wu, H., Momose, H., Rademaker, A., and Oyasu, R. Marked enhancement of rat urinary bladder carcinogenesis by heat-killed Escherichia coli. Cancer Res., 52, 5329-5333, 1992.
11. Kawai, K., Yamamoto, M., Kameyama, S., Kawamata, H., Rademaker, A., and Oyasu, R. Enhancement of rat urinary bladder tumorigenesis by lipopolysaccharide-induced inflammation. Cancer Res., 53: 5172-5175, 1993.
12. Kawai, K., Kawamata, H., Kameyama, S., Rademaker, A., and Oyasu, R. Persistence of carcinogen-altered cell population in rat urothelium which can be promoted to tumors by chronic inflammatory stimulus. Cancer Res., 54: 2630-2632, 1994.
13. Okamoto, M., Kawamata, H., Kawai, K., and Oyasu, R. Enhancement of transformation in vitro of a nontumorigenic rat urothelial cell line by interleukin-6. Cancer Res., 55: 4581-4585, 1995.
14. Siegall, C. B., Schwab, G., Nordan, R. P., FitzGerald, D. J., and Pastan, I. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res., 50: 7786-7788, 1990.
15. Siegsmund, M. J., Yamazaki, H., and Pastan, I. Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia. J. Urol., 151: 1396-1399, 1994.
16. Twillie, D. A., Eisenberger, M. A., Carducci, M. A., Hseih, W. S., Kim, W. Y., and Simons J. W. Interleukin-6: a candidate mediator of human prostate cancer morbidity. Urology, 45: 542-549, 1995.
17. Borsellino, N., Belldegrun, A., and Bonavida, B. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines. Cancer Res., 55: 4633-4639, 1995.
18. Sherwood, E. R., Fong, D. J., Lee, C., and Kozlowski, J. M. Basic fibroblast growth factor: a potential mediator of stromal growth in the human prostate. Endocrinology, 130: 2955-2963, 1992.
19. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63, 1983.
20. Berger, S. L., and Birkenmeier, C. S. Inhibition of intractable nucleases with ribonucleoside-vanadyl complexes: isolation of messenger ribonucleic acid from resting lymphocytes. Biochemistry, 18: 5143-5149, 1979.
21. Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., and Kishimoto, T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell, 63: 1149-1157, 1990.
22. Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., and Kishimoto, T. Cloning and expression of the human interleukin-6 (BSF-2/IFNβ 2) receptor. Science (Washington DC), 241: 825-828, 1988.
23. Mashiyama, S., Sekiya, T., and Hayashi, K. Screening of multiple DNA samples for detection of sequence changes. J. Methods Cell Mol. Biol., 2: 304, 1990.
24. Lee, C., Shvrin, D. H., and Kozlowski, J. M. In vivo and in vitro approaches to study metastasis in human prostatic cancer. Cancer Metastasis Rev., 12, 21-28, 1993.
25. Bauer, J., Bauer, T. M., Kalb, T., Taga, T., Lengyel, G., Hirano, T., Kishimoto, T., Acs, G., Mayer, L., and Gerok, W. Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. J. Exp. Med., 170: 1537-1549, 1989.
26. Zola, H., and Flego, L. Expression of interleukin-6 receptor on blood lymphocytes without in vitro activation. Immunology, 76: 338-340, 1992.
27. Cleave, M., Hsieh, J. T., Gao, C. A., von Eschenbach, A. C., and Chung, L. W. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res., 51: 3753-3761, 1991.
28. Yan, G., Fukabori, Y., Nikolaropolous, S., Wang, F., and McKeehan, W. L. Heparin-binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Mol. Endocrinol., 6: 2123-2128, 1992.
29. Sugimura, Y., Cunha, G. R., Haywood, S., Hayashi, N., Arima, K., and Kawamura, J. Keratinocyte growth factor (KGF) is a mediator of testosterone induced prostatic development. J. Urol., 151: 381A, 1994.
30. Humphrey, P. A., Zhu, X., Zarnegar, R., Swanson, P. E., Ratliff, T. L., Vollmer, R. T., and Day, M. L. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am. J. Pathol., 147: 386-396, 1995.